Literature DB >> 6337103

Histopathological study of protective immunity against murine salmonellosis induced by killed vaccine.

I Nakoneczna, H S Hsu.   

Abstract

Swiss-Webster mice were vaccinated with heat-killed salmonellae and then were infected with virulent Salmonella typhimurium. Only 1 of the 18 vaccinated mice died from a challenge of 10(4) X the 50% lethal dose, and about 70% of them survived a challenge of 10(5) X the 50% lethal dose. Histopathological examinations of the lesions developed in these vaccinated mice showed that they followed the characteristic features of a primary lesion in murine salmonellosis. There was an early necrosis with infiltration of polymorphonuclear leukocytes and abscess formation within the first 6 to 7 days after infection. However, these abscesses remained small and discrete. By days 7 to 10, the lesions began to transform into granulomas, first with the appearance of peripheral mononuclear cells and then by the replacement of polymorphs. By the third week of the infection, minute and discrete granulomas were seen scattered in the spleen, liver, and lymph nodes. Beyond this stage, healing and tissue regeneration followed. Thus, the characteristics of infectious lesions developed in mice vaccinated with heat-killed salmonellae are distinctly different from those developed in mice protected by the avirulent vaccine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337103      PMCID: PMC347955          DOI: 10.1128/iai.39.1.423-430.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Experimental salmonellosis. Intracellular growth of Salmonella enteritidis ingested in mononuclear phagocytes of mice, and cellular basis of immunity.

Authors:  S MITSUHASHI; I SATO; T TANAKA
Journal:  J Bacteriol       Date:  1961-06       Impact factor: 3.490

2.  Immunity in experimental salmonellosis. 3. Comparative immunization with viable and heat-inactivated cells of Salmonella typhimurium.

Authors:  R Germanier
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

Review 3.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

4.  Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice.

Authors:  F M Collins; G B Mackaness
Journal:  J Immunol       Date:  1968-11       Impact factor: 5.422

5.  Modification of macrophage function.

Authors:  R V Blanden
Journal:  J Reticuloendothel Soc       Date:  1968-06

6.  Cell-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.

Authors:  M R Venneman; L J Berry
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

7.  Effect of glucocorticosteroids on the phagocytosis and intracellular killing by peritoneal macrophages.

Authors:  T L Zwet; J Thompson; R Furth
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

8.  O antigen as virulence factor in mouse typhoid: effect of B-cell suppression.

Authors:  M V Valtonen; P Häyry
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

9.  The effect of T and B lymphocyte depletion on the protection of mice vaccinated with a Gal E mutant of Salmonella typhimurium.

Authors:  J A Morris; C Wray; W J Sojka
Journal:  Br J Exp Pathol       Date:  1976-06

10.  Bactericidal activity of fractionated granule contents from human polymorphonuclear leukocytes: antagonism of granule cationic proteins by lipopolysaccharide.

Authors:  M C Modrzakowski; J K Spitznagel
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

View more
  10 in total

1.  Local transfer of delayed-type hypersensitivity after Salmonella infection in mice.

Authors:  S R Attridge; I Kotlarski
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

2.  Confirmation of destruction of salmonellae within murine peritoneal exudate cells by immunocytochemical technique.

Authors:  F R Lin; H S Hsu; V R Mumaw; C W Moncure
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

3.  Phenotypic analysis of splenic lymphocytes and immunohistochemical study of hepatic granulomas after a murine infection with Salmonella abortusovis.

Authors:  L Guilloteau; D Buzoni-Gatel; F Blaise; F Bernard; M Pépin
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

4.  Cellular aspects of the longer-lasting immunity against mouse typhoid infection afforded by the live-cell and ribosomal vaccines.

Authors:  E Kita; M Emoto; K Yasui; K Yasui; N Katsui; K Nishi; S Kashiba
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

5.  Effect of iron on antibacterial immunity in vaccinated mice.

Authors:  I Kochan; S K Wagner; J Wasynczuk
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

6.  Recombinant Salmonella typhimurium strains that invade nonphagocytic cells are resistant to recognition by antigen-specific cytotoxic T lymphocytes.

Authors:  X M Gao; J P Tite; M Lipscombe; S Rowland-Jones; D J Ferguson; A J McMichael
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

7.  Recurrent Salmonella enteritidis sepsis and hepatic tuberculosis.

Authors:  M Trauner; E Grasmug; R E Stauber; H F Hammer; G Hoefler; E C Reisinger
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

8.  Comparative antibody response to Salmonella antigens in genetically resistant and susceptible mice.

Authors:  H R Xu; Y Y Tan; H S Hsu; C W Moncure; X M Wang
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

Review 9.  Pathogenesis and immunity in murine salmonellosis.

Authors:  H S Hsu
Journal:  Microbiol Rev       Date:  1989-12

10.  Contrasting roles of SPARC-related granuloma in bacterial containment and in the induction of anti-Salmonella typhimurium immunity.

Authors:  Gianluca Rotta; Gianluca Matteoli; Elisa Mazzini; Paolo Nuciforo; Mario P Colombo; Maria Rescigno
Journal:  J Exp Med       Date:  2008-03-03       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.